Zobrazeno 1 - 10
of 136
pro vyhledávání: '"Lipids"'
Autor:
Helkala EL; Department of Neurology, Kuopio University Hospital, Finland., Niskanen L, Viinamaki H, Partanen J, Uusitupa M
Publikováno v:
Diabetes care [Diabetes Care] 1995 May; Vol. 18 (5), pp. 681-5.
Autor:
Amée M. Buziau, Simone J.P.M. Eussen, M. Eline Kooi, Carla J.H. van der Kallen, Martien C.J.M. van Dongen, Nicolaas C. Schaper, Ronald M.A. Henry, Miranda T. Schram, Pieter C. Dagnelie, Marleen M.J. van Greevenbroek, Anke Wesselius, Otto Bekers, Steven J.R. Meex, Casper G. Schalkwijk, Coen D.A. Stehouwer, Martijn C.G.J. Brouwers
Publikováno v:
Diabetes Care, 45(5), 1116-1123. American Diabetes Association
OBJECTIVE Epidemiological evidence regarding the relationship between fructose intake and intrahepatic lipid (IHL) content is inconclusive. We, therefore, assessed the relationship between different sources of fructose and IHL at the population level
Autor:
Elizabeth R. Seaquist, Heidi Krause-Steinrauf, José A. Luchsinger, Mary E. Larkin, Corinna Falck-Ytter, Jennifer J. Manly, Joshua I. Barzilay, Naji Younes, Hermes Florez, Rodica Pop-Busui, Willy Marcos Valencia
Publikováno v:
Diabetes care, vol 44, iss 10
Diabetes Care
Diabetes Care
OBJECTIVE Type 2 diabetes is a risk factor for cognitive impairment. We examined the relation of glycemia, lipids, blood pressure (BP), hypertension history, and statin use with cognition in the Glycemia Reduction Approaches in Diabetes: A Comparativ
Autor:
Estefanía Toledo, Jordi Salas-Salvadó, Dong D. Wang, Dora Romaguera, Marta Guasch-Ferré, Lluis Serra-Majem, Christopher Papandreou, Liming Liang, Mònica Bulló, Cristina Razquin, Edward Yu, Courtney Dennis, Clary B. Clish, Miguel Ángel Martínez-González, Frank B. Hu, Dolores Corella, Enrique Gómez-Gracia, Ángel M. Alonso-Gómez, Miguel Ruiz-Canela, Montserrat Fitó, Emilio Ros, Amy Deik, Ramon Estruch, José Lapetra
Publikováno v:
Diabetes Care. 41:2617-2624
OBJECTIVE Specific lipid molecular changes leading to type 2 diabetes (T2D) are largely unknown. We assessed lipidome factors associated with future occurrence of T2D in a population at high cardiovascular risk. RESEARCH DESIGN AND METHODS We conduct
Publikováno v:
Diabetes Care. 43:1673-1678
The American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines recently published its 2018 recommendations on management of LDL cholesterol (LDL-C) in people with diabetes. For primary prevention, moderate-in
Autor:
Kai Simons, Mathias J. Gerl, Nikolay Oskolkov, Michal A. Surma, Christian Klose, Filip Ottosson, Ulrika Ericson, Olle Melander, Céline Fernandez, Marju Ohro-Melander
Publikováno v:
Diabetes Care. 43:366-373
OBJECTIVE Type 2 diabetes mellitus (T2DM) is associated with dyslipidemia, but the detailed alterations in lipid species preceding the disease are largely unknown. We aimed to identify plasma lipids associated with development of T2DM and investigate
Autor:
Tomas Vaisar, Angela Irwin, Karin E. Bornfeldt, George L. King, Hetal Shah, Hillary A. Keenan, I-Hsien Wu, Carla J. Greenbaum, John Gauthier, Vanessa Bahnam, Jake Wimberger, Jay W. Heinecke, Emily Wolfson, Jenny E. Kanter
Publikováno v:
Diabetes Care
OBJECTIVE A subset of people with long-standing type 1 diabetes (T1D) appears to be protected from microvascular and macrovascular complications. Previous studies have focused on improved abilities to respond to glucose and its downstream effects as
Publikováno v:
Diabetes Care. 42:644-650
OBJECTIVE Individualized treatment of patients with diabetes requires detailed evaluation of risk factor dynamics at the population level. This study evaluated the persistent glycemic and cardiovascular (CV) risk factor burden over 2 years after trea
Autor:
Hye Soo Chung, Sin Gon Kim, Jung A. Kim, Nam Hoon Kim, Hye Jin Yoo, Sei Hyun Baik, You-Bin Lee, Ji A Seo, Kyung Mook Choi, Nan Hee Kim, Eun Roh, Ji Sung Lee, So Hyeon Hong
Publikováno v:
Diabetes Care. 41:2610-2616
OBJECTIVE Although increasing evidence suggests the association between short-term variability of fasting plasma glucose (FPG) and diabetic complications or mortality, the impact of visit-to-visit variability of FPG on the development of type 2 diabe
Autor:
Anna V. Mathew, Lei Li, Rodica Pop-Busui, Jaeman Byun, Mamta Jaiswal, Subramaniam Pennathur, Yanhong Guo, George Michailidis, Y. Eugene Chen
Publikováno v:
Diabetes Care
OBJECTIVE Phagocyte-derived myeloperoxidase (MPO) and proinflammatory HDL are associated with metabolic syndrome (MetS) and increased cardiovascular disease risk. Therapeutic lifestyle changes (TLCs), such as a Mediterranean diet and exercise, decrea